Clinical trials in the modern medical era began in the mid-20th century with the first randomized, doubleblind assessment of an antibiotic, streptomycin, for the treatment of pulmonary tuberculosis.1 Over the course of the next 50 years, the randomized, controlled trial became the “gold standard” for testing the efficacy of new therapies and is generally required for their approval by regulator...